All Posts | Links Medicus - Free Medical News & Perspective

Our October Issue Editorial:#Insulin for all: a hope yet to be realised https://t.co/LMYLFrRsh0 #InsulinCentenary #insulin100 #insulin4all #diabetes #FREE to read pic.twitter.com/OvNqmIijeg

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) September 15, 2021

Systematic Review: Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose?

16 Sep, 2021 | 09:55h | UTC

Summary: Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? – Cochrane Library

Original Study: Electronic cigarettes for smoking cessation – Cochrane Library

Commentary on Twitter

Can #ecigarettes help you #quitsmoking? Latest Evidence is in! https://t.co/04UN47MoOm pic.twitter.com/pDugyzeEmh

— CochraneTAG (@CochraneTAG) September 14, 2021

Guidelines for the surveillance and survivorship care of patients after curative treatment of colon and rectal cancer.

16 Sep, 2021 | 09:52h | UTC

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surveillance and Survivorship Care of Patients After Curative Treatment of Colon and Rectal Cancer – Diseases of the Colon & Rectum

Commentary on Twitter

Clinical Practice Guidelines – Surveillance and Survivorship shown in #DCRJournal visual abstract by @ianmpaquette @JMigaly @ASCRS_1. What do you think? https://t.co/e3kADOerpq @JISBMD @ConorDelaneyMD @justinmaykel @KarimAlavi @KyleCologne @dubaicolorectal @SamAtallahMD pic.twitter.com/wOhu0Mby60

— DCRjournal (@DCRjournal) May 9, 2021

Systematic Review: Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

16 Sep, 2021 | 09:53h | UTC

Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy – Cochrane Library

Summary: Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous kidney replacement therapy – Cochrane Library

Consensus Guideline: Liver transplantation for non-resectable colorectal liver metastases.

16 Sep, 2021 | 09:50h | UTC

Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines – The Lancet Gastroenterology & Hepatology (free registration required)

Commentary on Twitter

New online – Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelineshttps://t.co/oZL4X4h7VS @IHPBA @gbonneysurg @eahpba @_ilts_#livertwitter #APHPBA_2021 pic.twitter.com/g6rrVclV5h

— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 8, 2021

A guide to the treatment of cellulitis and other soft-tissue infections.

16 Sep, 2021 | 09:47h | UTC

A guide to the Tx of cellulitis and other soft-tissue infections – Journal of Family Practice

Cluster RCT: Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission.

15 Sep, 2021 | 10:01h | UTC

Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial – The Lancet

Invited commentary: Daily antigen testing to reduce disruption when schools return – The Lancet

Five hundred patients with gut malrotation: thirty years of experience with the introduction of a new surgical procedure.

16 Sep, 2021 | 09:48h | UTC

Five Hundred Patients With Gut Malrotation: Thirty Years of Experience With the Introduction of a New Surgical Procedure – Annals of Surgery

RCT: Remdesivir does not improve outcomes in patients admitted to hospital with COVID-19.

15 Sep, 2021 | 09:59h | UTC

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial – The Lancet Infectious Diseases

Invited commentary: Remdesivir, on the road to DisCoVeRy – The Lancet Infectious Diseases

Systematic Review: “Remdesivir probably has little or no effect on all‐cause mortality at up to 28 days in hospitalized adults with SARS‐CoV‐2 infection. We are uncertain about the effects of remdesivir on clinical improvement and worsening”.

WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19

Review | Prevention of host-to-host transmission by SARS-CoV-2 vaccines.

15 Sep, 2021 | 09:16h | UTC

Prevention of host-to-host transmission by SARS-CoV-2 vaccines – The Lancet Infectious Diseases

Study ties COVID vaccines to lower transmission rates.

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England – “the likelihood of household transmission was approximately 40 to 50% lower in households of index patients who had been vaccinated 21 days or more before testing positive than in households of unvaccinated index patients”.

Study in England showed one dose of COVID-19 vaccine can cut household transmission by up to half – This protection is on top of the reduced risk of a vaccinated person developing symptomatic infection, which is around 60 to 65% after the first dose

Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members.

Ivermectin: Cochrane’s most talked about review so far, ever. Why?

15 Sep, 2021 | 09:07h | UTC

Ivermectin: Cochrane’s most talked about review so far, ever. Why? – Cochrane Library

Original review: Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

Commentary on Twitter

Ivermectin: Cochrane’s most talked about review so far, ever. Why?https://t.co/KmOLR9qHrF #ivermectin #evidencesynthesis #systematicreviews #COVID19 #Cochrane #publichealth #globalhealth #medicine pic.twitter.com/twLyqzSrcF

— Cochrane US Network (@Cochrane_US) September 14, 2021

Supplement: FIGO Working Group for Preterm Birth – Good Practice Recommendations.

15 Sep, 2021 | 08:56h | UTC

Homepage: FIGO Working Group for Preterm Birth – Good Practice Recommendations – International Journal of Gynecology & Obstetrics

Editorial: FIGO good practice recommendations for reducing preterm birth and improving child outcomes

FIGO good practice recommendations on the importance of registry data for monitoring rates and health systems performance in prevention and management of preterm birth

FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth

FIGO good practice recommendations on reduction of preterm birth in pregnancies conceived by assisted reproductive technologies

FIGO good practice recommendations on progestogens for prevention of preterm delivery

FIGO good practice recommendations on cervical cerclage for prevention of preterm birth

FIGO good practice recommendations on the use of pessary for reducing the frequency and improving outcomes of preterm birth

FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm

FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection

FIGO good practice recommendations on delayed umbilical cord clamping

CDC report finds unvaccinated people are 11 times more likely to die of COVID-19.

15 Sep, 2021 | 09:09h | UTC

Unvaccinated People Are 11 Times More Likely To Die Of COVID-19, New Research Finds – NPR

Original study: Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 – CDC Morbidity and Mortality Weekly Report

Commentary on Twitter

New @CDCMMWR shows fully vaccinated people had >10x lower risk of hospitalization or death from #COVID19 compared with those not fully vaccinated. The best way to protect yourself & those around you is to #SleeveUp. More: https://t.co/7GBRXOApe7. pic.twitter.com/Te4CyBJZsy

— CDC (@CDCgov) September 10, 2021

The tangled history of mRNA vaccines.

15 Sep, 2021 | 09:06h | UTC

The tangled history of mRNA vaccines – Nature

mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.

Commentary on Twitter

What an outstanding ★ feature on the long history of mRNA vaccines and their future potential, by @ElieDolgin @Nature https://t.co/PZ1eFFnRsi pic.twitter.com/CjeS4vq0gx

— Eric Topol (@EricTopol) September 14, 2021